PROInsulet Corporation
stock139.81
+4.53 (+3.35%)
Price as of 13 Oct, 14:36 · Rate limit reached. Please try again in a minute.
Good Money Guide Pro Score
Weak
Weak investment profile
Technical Analysis
Short-Term Outlook
Bullish
2 bull · 1 bear · 2 neutral
Medium-Term Outlook
Neutral
2 bull · 2 bear · 0 neutral
Price below 50-day MA
Price below 200-day MA
Price above 12-day EMA
Price above 26-day EMA
Neutral momentum zone
MACD above signal line
Overbought — potential reversal down
Price near middle band
Volatility measure — informational only
Volume Indicators
On Balance Volume (OBV)
Volume Accumulation Distribution (VAD)
Market Statistics
Day Change
+4.53
Market Cap
11363561000
Exchange
NASDAQ
Sector
Health Care
Fundamentals
Rate limit reached. Please try again in a minute.
Analyst Forecast
Rate limit reached. Please try again in a minute.
Fundamental Analysis
Unable to load fundamental data
Learn about Insulet Corporation
What is Insulet Corporation?
Insulet Corporation is a medical device company primarily known for developing the Omnipod, a tubeless, wearable insulin pump system. The device allows individuals with insulin-dependent diabetes to manage their glucose levels discreetly and automatically through a wireless controller. By simplifying insulin delivery, the company aims to improve the daily quality of life for its patients.
Is Insulet Corporation a good investment?
On the positive side, Insulet benefits from a growing global diabetic population and strong recurring revenue through its disposable pod sales. However, the company faces significant competition from other medical technology giants and must navigate complex healthcare reimbursement policies that could impact profit margins. Please note that this information is for educational purposes only and does not constitute financial advice.
How do you invest in Insulet Corporation?
To invest in Insulet, you can purchase shares of PODD directly through a brokerage account that provides access to the NASDAQ stock exchange. Alternatively, you can gain exposure by investing in healthcare-focused exchange-traded funds (ETFs) or mutual funds that include Insulet as part of their broader portfolio holdings.
Educational content generated by AI — not financial advice.
Time & Sales
No trades yet.
News & Sentiment
Rate limit reached. Please try again in a minute.
Community Discussion
No posts yet for PODD — be the first to start the discussion.
Point & Figure Analysis
OHLC
Signals
as of 07 Oct 2026Targets
No active targets — trend is consolidating.
Famous Investors Holding PODD
Ken Griffin
796.6K sh · 0.0% of portfolio
$121.28M
NEW
Jim Simons
202.1K sh · 0.0% of portfolio
$30.77M
NEW
Ray Dalio
156.4K sh · 0.1% of portfolio
$23.81M
NEW
Ken Fisher
55.7K sh · 0.0% of portfolio
$8.49M
NEW
Ken Griffin
34.8K sh · 0.0% of portfolio
$5.30M
NEW
Ken Griffin
30.2K sh · 0.0% of portfolio
$4.60M
NEW
Ken Griffin
141 sh · 0.0% of portfolio
$21.5K
NEW
Source: SEC Form 13F, reporting period 30 Jun 2026. 45-day lag applies.